Canlyniadau Chwilio - X. Cynthia

Mireinio'r Canlyniadau
  1. 1
    Letrozole in the neoadjuvant setting: the P024 trial

    Letrozole in the neoadjuvant setting: the P024 trial gan Matthew J. Ellis, X. Cynthia

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy

    Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy gan Parvin F. Peddi, Matthew J. Ellis, X. Cynthia

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics

    Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics gan X. Cynthia, James W. Janetka, Helen Piwnica‐Worms

    Cyhoeddwyd 2010
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer

    Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer gan Sandeep Rajput, Nimmish Khera, Zhanfang Guo, Jeremy Hoog, Shunqiang Li, X. Cynthia

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians

    Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians gan Foluso O. Ademuyiwa, Tao Yu, Jingqin Luo, Katherine N. Weilbaecher, X. Cynthia

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in <scp>US</scp> women 18 to 64 years old

    Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in <scp>US</scp> women 18 to 64 years old gan Christine D. Hsu, Xiaoyan Wang, David V. Habif, X. Cynthia, Kimberly Johnson

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    <i>HER2</i>-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor

    <i>HER2</i>-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor gan Noa Ben-Baruch, Ron Bose, Shyam M. Kavuri, X. Cynthia, Matthew J. Ellis

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models

    Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models gan Siguang Xu, Shunqiang Li, Zhanfang Guo, Jingqin Luo, Matthew J. Ellis, X. Cynthia

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1.

    Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. gan Dror I. Baruch, J A Gormely, X. Cynthia, R J Howard, B L Pasloske

    Cyhoeddwyd 1996
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy

    Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy gan Farrokh Dehdashti, Ningying Wu, X. Cynthia, Michael Naughton, John A. Katzenellenbogen, Barry A. Siegel

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Protein Subcellular Localization Profiling of Breast Cancer Cells by Dissociable Antibody MicroArray (DAMA) Staining

    Protein Subcellular Localization Profiling of Breast Cancer Cells by Dissociable Antibody MicroArray (DAMA) Staining gan Fu, Guanyuan, Song, X. Cynthia, Yang, Xufen, Peng, Tao, Wang, Yingjian, Zhou, G. Wayne

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Cost–effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice

    Cost–effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice gan Schackman, Bruce R, Haas, David W, Park, Sanghee S, Li, X Cynthia, Freedberg, Kenneth A

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    US breast cancer mortality trends in young women according to race

    US breast cancer mortality trends in young women according to race gan Foluso O. Ademuyiwa, Feng Gao, Hao Lin, Daniel Morgensztern, Rebecca Aft, X. Cynthia, Matthew J. Ellis

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer

    Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer gan Beomyoung Cho, Yunan Han, Min Lian, Graham A. Colditz, Jason D. Weber, X. Cynthia, Ying Liu

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response

    Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Resp... gan Carla S. Fisher, X. Cynthia, William E. Gillanders, Rebecca Aft, Timothy J. Eberlein, Feng Gao, Julie A. Margenthaler

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

    Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer gan César Sánchez, X. Cynthia, Robert J. Crowder, Therese Guintoli, Chanpheng Phommaly, Feng Gao, Lin Li, Matthew J. Ellis

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells

    Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells gan Venkataswarup Tiriveedhi, Timothy P. Fleming, Peter S. Goedegebuure, Michael Naughton, X. Cynthia, Craig Lockhart, Feng Gao, William E. Gillanders, T. Mohanakumar

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs

    Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs gan Tahir Rahman, John M. Sahrmann, Margaret A. Olsen, Katelin B. Nickel, J. Philip Miller, X. Cynthia, Richard A. Grucza

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma

    Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma gan X. Cynthia, Martha Q. Lacy, John F. Rompala, Angela Dispenzieri, S. Vincent Rajkumar, Philip R. Greipp, Rafaël Fonseca, Robert A. Kyle, Morie A. Gertz

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib for Postmenopausal Women With Hormone Receptor–Positive Advanced Breast Cancer—CALGB 40302 (Alliance)

    Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase... gan Harold J. Burstein, Constance Cirrincione, William T. Barry, Helen K. Chew, Sara M. Tolaney, Diana Lake, X. Cynthia, Kimberly Blackwell, Eric P. Winer, Clifford A. Hudis

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: